Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Chronic Heart Failure

Free Subscription 25.07.2022 6 Am J Cardiol 1 Cardiol Clin 1 Circ Cardiovasc Qual Outcomes 2 Circ Heart Fail 1 Circ Res 5 Circulation 1 Clin Cardiol 3 Eur Heart J 9 Eur J Heart Fail 3 Heart 1 Hypertension 5 Int J Cardiol 4 J Am Coll Cardiol 13 J Card Fail 1 J Mol Cell Cardiol 1 J Thorac Cardiovasc Surg 4 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Cardiol

1. TRUONG VT, Egnaczyk GF, O'Brien TM, Raymond TE, et al
   Left Ventricular Assist Device in Patients With Alcohol Abuse or Illicit Drug Use.
   Am J Cardiol. 2022;177:61-68.
   PubMed         Abstract available
   
   
2. ZAHID S, Hashem A, Atti V, Khan MZ, et al
   Outcomes of 30-Day Readmission in Patients With Heart Failure on Index Hospitalization Who Underwent Transcatheter Aortic Valve Implantation (from the US Nationwide Readmissions Database).
   Am J Cardiol. 2022 Jul 16. pii: S0002-9149(22)00638.
   PubMed        
   
   
3. CLARKSON SA, Cherrington A, Heindl B, Judd SE, et al
   Establishing Care Post Discharge Following a Heart Failure Hospitalization in an Uninsured Heart Failure Population.
   Am J Cardiol. 2022 Jul 16. pii: S0002-9149(22)00644.
   PubMed         Abstract available
   
   
4. NISHIGOORI S, Shirakabe A, Okazaki H, Matsushita M, et al
   Trends in Sudden Death Following Admission for Acute Heart Failure.
   Am J Cardiol. 2022 Jul 10. pii: S0002-9149(22)00587.
   PubMed         Abstract available
   
   
5. GAVAZZONI M, Zuber M, Taramasso M, Cascella A, et al
   Transesophageal Echocardiography For The Assessment of Left Atrial Pressure After Trans-Septal Mitral Valve Interventions.
   Am J Cardiol. 2022 Jun 21. pii: S0002-9149(22)00528.
   PubMed         Abstract available
   
   
6. POTERUCHA TJ, Kurian D, Raiszadeh F, Teruya S, et al
   Relation of Body Mass Index to Transthyretin Cardiac Amyloidosis Particularly in Black and Hispanic Patients (from the SCAN-MP Study).
   Am J Cardiol. 2022;177:116-120.
   PubMed         Abstract available
   
   

   
   Cardiol Clin

7. DAMLUJI AA, Gangasani NR, Grines CL
   Mechanical Complication of Acute Myocardial Infarction Secondary to COVID-19 Disease.
   Cardiol Clin. 2022;40:365-373.
   PubMed         Abstract available
   
   

   
   Circ Cardiovasc Qual Outcomes

8. REINHARDT SW, Clark KAA, Xin X, Parzynski CS, et al
   Thirty-Day and 90-Day Episode of Care Spending Following Heart Failure Hospitalization Among Medicare Beneficiaries.
   Circ Cardiovasc Qual Outcomes. 2022;15:e008069.
   PubMed         Abstract available
   
   

   
   Circ Heart Fail

9. SEO M, Watanabe T, Yamada T, Yano M, et al
   Clinical Determinants of Quality of Life in Patients With Acute Decompensated Heart Failure With Preserved Ejection Fraction: Insights From the PURSUIT-Heart Failure With Preserved Ejection Fraction Registry.
   Circ Heart Fail. 2022 Jul 21:101161CIRCHEARTFAILURE122009789.
   PubMed        
   
   
10. ELKHOLEY K, Niewiadomska M, Morris L, Whyte S, et al
    Transcutaneous Vagus Nerve Stimulation Ameliorates the Phenotype of Heart Failure With Preserved Ejection Fraction Through Its Anti-Inflammatory Effects.
    Circ Heart Fail. 2022 Jul 7:101161CIRCHEARTFAILURE122009288.
    PubMed         Abstract available
    
    

    
    Circ Res

11. DOIRON JE, Lefer DJ
    Leveraging Adipocyte-Cardiomyocyte Signaling to Treat Ischemic Heart Failure.
    Circ Res. 2022;131:165-167.
    PubMed        
    
    

    
    Circulation

12. ROSCH S, Kresoja KP, Besler C, Fengler K, et al
    Characteristics of Heart Failure With Preserved Ejection Fraction Across the Range of Left Ventricular Ejection Fraction.
    Circulation. 2022 Jul 8:101161CIRCULATIONAHA122059280.
    PubMed         Abstract available
    
    
13. BRITTAIN EL, Thenappan T, Huston JH, Agrawal V, et al
    Elucidating the Clinical Implications and Pathophysiology of Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction: A Call to Action: A Science Advisory From the American Heart Association.
    Circulation. 2022 Jul 11:101161CIR0000000000001079.
    PubMed         Abstract available
    
    
14. TONG D, Schiattarella GG, Jiang N, Daou D, et al
    Impaired AMP-Activated Protein Kinase Signaling in Heart Failure With Preserved Ejection Fraction-Associated Atrial Fibrillation.
    Circulation. 2022;146:73-76.
    PubMed        
    
    
15. PETERSON LR, Coggan AR
    Heart Failure With Reduced Ejection Fraction: "The Importance of Being Frail".
    Circulation. 2022;146:91-93.
    PubMed        
    
    
16. POKORNEY SD, Granger CB
    Evidence Builds for Catheter Ablation for Atrial Fibrillation and Heart Failure.
    Circulation. 2022;145:1705-1707.
    PubMed        
    
    

    
    Clin Cardiol

17. FREEDMAN BL, Berg DD, Scirica BM, Bohula EA, et al
    Epidemiology of heart failure hospitalization in patients with stable atherothrombotic disease: Insights from the TRA 2 degrees P-TIMI 50 trial.
    Clin Cardiol. 2022 Jul 19. doi: 10.1002/clc.23843.
    PubMed         Abstract available
    
    

    
    Eur Heart J

18. HADWIGER M, Dagres N, Haug J, Wolf M, et al
    Survival of patients undergoing cardiac resynchronization therapy with or without defibrillator: the RESET-CRT project.
    Eur Heart J. 2022;43:2591-2599.
    PubMed         Abstract available
    
    
19. FRANTZ S, Hundertmark MJ, Schulz-Menger J, Bengel FM, et al
    Left ventricular remodelling post-myocardial infarction: pathophysiology, imaging, and novel therapies.
    Eur Heart J. 2022 May 4. pii: 6578707. doi: 10.1093.
    PubMed         Abstract available
    
    
20. VERGALLO R, Volpe M
    Deciphering a decision support tool (CoDE-HF) to improve the diagnosis of acute heart failure.
    Eur Heart J. 2022 Jul 22. pii: 6648207. doi: 10.1093.
    PubMed        
    
    

    
    Eur J Heart Fail

21. VADUGANATHAN M, Ferreira JP, Rossignol P, Neuen B, et al
    Effects of Steroidal Mineralocorticoid Receptor Antagonists on Acute and Chronic Estimated Glomerular Filtration Rate Slopes in Patients with Chronic Heart Failure.
    Eur J Heart Fail. 2022 Jul 22. doi: 10.1002/ejhf.2635.
    PubMed         Abstract available
    
    
22. SALAH HM, Fudim M
    Tolerability and Safety Barriers of SGLT2 Inhibitors Initiation in Heart Failure with Reduced Ejection Fraction.
    Eur J Heart Fail. 2022 Jul 22. doi: 10.1002/ejhf.2633.
    PubMed        
    
    
23. BROMAGE DI, Cannata A, McDonagh TA
    Combination diuretic therapy for acute heart failure: "Alone we can do so little; together we can do so much".
    Eur J Heart Fail. 2022 Jul 22. doi: 10.1002/ejhf.2634.
    PubMed        
    
    
24. METRA M, Chioncel O, Cotter G, Davison B, et al
    Safety and Efficacy of Istaroxime for Patients with Acute-Heart-Failure-Related Pre-cardiogenic Shock - A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study (SEISMiC).
    Eur J Heart Fail. 2022 Jul 22. doi: 10.1002/ejhf.2629.
    PubMed         Abstract available
    
    
25. CARAVITA S, Faini A, Vignati C, Pelucchi S, et al
    Intravenous iron therapy improves the hypercapnic ventilatory response and sleep disordered breathing in chronic heart failure.
    Eur J Heart Fail. 2022 Jul 22. doi: 10.1002/ejhf.2628.
    PubMed         Abstract available
    
    
26. PAPALIA F, Charles-Edwards G, Okonko DO
    Reply to the letter regarding the article "Cardiac Energetics in Patients with Chronic Heart Failure and Iron Deficiency: An in-vivo 31P Magnetic Resonance Study".
    Eur J Heart Fail. 2022 Jul 19. doi: 10.1002/ejhf.2625.
    PubMed        
    
    
27. LINDE C, Grabowski M, Ponikowski P, Rao I, et al
    Cardiac Contractility Modulation Therapy Improves Health Status in Patients with Heart Failure with Preserved Ejection Fraction; a Pilot Study (CCM-HFpEF).
    Eur J Heart Fail. 2022 Jul 20. doi: 10.1002/ejhf.2619.
    PubMed         Abstract available
    
    
28. TOMASONI D, Aimo A, Merlo M, Nardi M, et al
    Value of the HFA-PEFF and H2 FPEF scores in patients with heart failure and preserved ejection fraction caused by cardiac amyloidosis.
    Eur J Heart Fail. 2022 Jul 20. doi: 10.1002/ejhf.2616.
    PubMed         Abstract available
    
    
29. BAYES-GENIS A, Aimo A, Lupon J
    Empagliflozin in heart failure with preserved and mildly reduced ejection fraction: prognostic benefit confirmed with different endpoint definitions.
    Eur J Heart Fail. 2022 Jul 4. doi: 10.1002/ejhf.2597.
    PubMed        
    
    

    
    Heart

30. STRAW S, Mullens W, Witte KK
    Cardiac resynchronisation therapy with or without a defibrillator: individualising device prescription.
    Heart. 2022;108:1164-1166.
    PubMed        
    
    
31. MAILLE B, Bodin A, Bisson A, Herbert J, et al
    Predicting outcome after cardiac resynchronisation therapy defibrillator implantation: the cardiac resynchronisation therapy defibrillator Futility score.
    Heart. 2022;108:1186-1193.
    PubMed         Abstract available
    
    
32. BELZILE D, Senechal M
    Microstructure: a potential path to elucidate sex-specific pathological mechanisms in heart failure?
    Heart. 2022 Jul 14. pii: heartjnl-2022-321250. doi: 10.1136/heartjnl-2022-321250
    PubMed        
    
    

    
    Hypertension

33. BRANDT M, Dorschmann H, Khraisat S, Knopp T, et al
    Telomere Shortening in Hypertensive Heart Disease Depends on Oxidative DNA Damage and Predicts Impaired Recovery of Cardiac Function in Heart Failure.
    Hypertension. 2022 Jul 18:101161HYPERTENSIONAHA12118935.
    PubMed         Abstract available
    
    

    
    Int J Cardiol

34. STAMATELOPOULOS K, Delialis D, Georgiopoulos G, Tselegkidi MI, et al
    Determining patterns of vascular function and structure in wild-type transthyretin cardiac amyloidosis. A comparative study.
    Int J Cardiol. 2022;363:102-110.
    PubMed         Abstract available
    
    
35. ATTAR R, Valentin JB, Andell P, Nielsen RE, et al
    Major adverse cardiovascular events following acute coronary syndrome in patients with bipolar disorder.
    Int J Cardiol. 2022;363:1-5.
    PubMed         Abstract available
    
    
36. BAUDO M, D'Ancona G, Trinca F, Rosati F, et al
    Atrioventricular node ablation and pacing for atrial tachyarrhythmias: A meta-analysis of postoperative outcomes.
    Int J Cardiol. 2022 Jun 25. pii: S0167-5273(22)01011.
    PubMed         Abstract available
    
    
37. GODINO C, Scotti A, Marengo A, Battini I, et al
    Effectiveness and cost-efficacy of diuretics home administration via peripherally inserted central venous catheter in patients with end-stage heart failure.
    Int J Cardiol. 2022 Jul 16. pii: S0167-5273(22)01095.
    PubMed         Abstract available
    
    
38. AUSTIN DE, Lee DS, Wang CX, Ma S, et al
    Comparison of machine learning and the regression-based EHMRG model for predicting early mortality in acute heart failure.
    Int J Cardiol. 2022 Jul 19. pii: S0167-5273(22)01105.
    PubMed         Abstract available
    
    

    
    J Am Coll Cardiol

39. BADRAN S, Lee S
    Even in Heart Failure, Integrating Palliative Care and Aggressive Medical Therapy Is a Thing.
    J Am Coll Cardiol. 2022;80:345-347.
    PubMed        
    
    
40. CHANG YK, Allen LA, McClung JA, Denvir MA, et al
    Criteria for Referral of Patients With Advanced Heart Failure for Specialized Palliative Care.
    J Am Coll Cardiol. 2022;80:332-344.
    PubMed         Abstract available
    
    
41. KOCHAR A, Smilowitz NR, Hochman JS
    Dynamic Cardiogenic Shock Classification: 2 Steps Forward, 1 Step Back.
    J Am Coll Cardiol. 2022;80:199-201.
    PubMed        
    
    
42. KAPUR NK, Kanwar M, Sinha SS, Thayer KL, et al
    Criteria for Defining Stages of Cardiogenic Shock Severity.
    J Am Coll Cardiol. 2022;80:185-198.
    PubMed         Abstract available
    
    

    
    J Card Fail

43. KHAN MS, Butler J, Vaduganathan M, Greene SJ, et al
    Heart Failure Specific Versus All-Cause Endpoints in Heart Failure Clinical Trials.
    J Card Fail. 2022 Jul 14. pii: S1071-9164(22)00582.
    PubMed        
    
    
44. SINHA SS, Bohula EA, van Diepen S, Leonardi S, et al
    The Intersection between Heart Failure and Critical Care Cardiology: An International Perspective on Structure, Staffing, and Design Considerations.
    J Card Fail. 2022 Jul 14. pii: S1071-9164(22)00579.
    PubMed         Abstract available
    
    
45. CHUZI S, Pensa AV, Allen LA, Cross SH, et al
    Palliative Care for Patients with Heart Failure: Results from a Heart Failure Society of America Survey.
    J Card Fail. 2022 Jul 13. pii: S1071-9164(22)00578.
    PubMed         Abstract available
    
    
46. DRAZNER MH
    The Next Generation.
    J Card Fail. 2022;28:1240-1241.
    PubMed        
    
    
47. SAUER AJ
    Vulnerability Makes Way for Belonging at Work and in Life.
    J Card Fail. 2022;28:1048-1049.
    PubMed        
    
    
48. DORBALA S, Ando Y, Bokhari S, Dispenzieri A, et al
    Addendum to ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 1 of 2-Evidence Base and Standardized Methods of Imaging.
    J Card Fail. 2022;28:e1-e4.
    PubMed        
    
    
49. DEFILIPPIS EM, Truby LK, Clerkin KJ, Donald E, et al
    Increased Opportunities for Transplantation for Women in the New Heart Allocation System.
    J Card Fail. 2022;28:1149-1157.
    PubMed         Abstract available
    
    
50. WANG T, Day SM, Goldberg LR, Owens AT, et al
    A Parallel Need for Cardiovascular Care for Female Carriers of Duchenne and Becker Muscular Dystrophy.
    J Card Fail. 2022;28:1235-1236.
    PubMed        
    
    
51. GARRY DJ, Kamdar F, Alexy T
    Dystrophic Cardiomyopathy and Patients With Muscular Dystrophies.
    J Card Fail. 2022;28:1237-1239.
    PubMed        
    
    
52. KANWAR MK, Pagani FD, Mehra MR, Estep JD, et al
    Center Variability in Patient Outcomes Following HeartMate 3 Implantation: An Analysis of the MOMENTUM 3 Trial.
    J Card Fail. 2022;28:1158-1168.
    PubMed         Abstract available
    
    
53. CODE J
    From Patient to Agent.
    J Card Fail. 2022;28:1230-1234.
    PubMed        
    
    
54. ALI HR, Valero-Elizondo J, Wang SY, Cainzos-Achirica M, et al
    Subjective Financial Hardship from Medical Bills Among Patients with Heart Failure in the United States: The 2014-2018 Medical Expenditure Panel Survey.
    J Card Fail. 2022 Jul 12. pii: S1071-9164(22)00576.
    PubMed         Abstract available
    
    
55. LALA A, Mentz RJ
    Fostering Belonging at JCF.
    J Card Fail. 2022;28:1047.
    PubMed        
    
    

    
    J Mol Cell Cardiol

56. MARTENS P, Nguyen C, Tang WHW
    Is epicardial adipose tissue a key pathophysiologic target in heart failure with preserved ejection?
    J Mol Cell Cardiol. 2022;171:69-70.
    PubMed        
    
    

    
    J Thorac Cardiovasc Surg

57. BEDZRA EKS, Adachi I, Peng DM, Amdani S, et al
    Systemic ventricular assist device support of the Fontan circulation yields promising outcomes: An analysis of The Society of Thoracic Surgeons Pedimacs and Intermacs Databases.
    J Thorac Cardiovasc Surg. 2022;164:353-364.
    PubMed         Abstract available
    
    

    
    PLoS One

58. TIGABE TEKLE M, Bekalu AF, Tefera YG
    Length of hospital stay and associated factors among heart failure patients admitted to the University Hospital in Northwest Ethiopia.
    PLoS One. 2022;17:e0270809.
    PubMed         Abstract available
    
    
59. WU J, Wang W, Huang Y, Wu H, et al
    Deletion of SM22alpha disrupts the structure and function of caveolae and T-tubules in cardiomyocytes, contributing to heart failure.
    PLoS One. 2022;17:e0271578.
    PubMed         Abstract available
    
    
60. KIM Y, Canada JM, Kenyon J, Billingsley H, et al
    Physical activity, sedentary behaviors and all-cause mortality in patients with heart failure: Findings from the NHANES 2007-2014.
    PLoS One. 2022;17:e0271238.
    PubMed         Abstract available
    
    
61. ZHU L, Marsh JW, Griffith MP, Collins K, et al
    Predictive model for severe COVID-19 using SARS-CoV-2 whole-genome sequencing and electronic health record data, March 2020-May 2021.
    PLoS One. 2022;17:e0271381.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Chronic Heart Failure is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: